Complete protection against interleukin-1beta-induced functional suppression and cytokine-mediated cytotoxicity in rat pancreatic islets in vitro using an interleukin-1 cytokine trap

Diabetes
Tobias RydgrenStellan Sandler

Abstract

Cytokines, particularly interleukin (IL)-1beta, have been postulated to cause beta-cell destruction in type 1 diabetes. We tested the efficacy of an IL-1 cytokine trap in counteraction of suppressive and toxic effects after exposure of rat pancreatic islets in vitro to IL-1beta. The IL-1 cytokine trap used herein comprised extracellular domains of the IL-1 receptor accessory protein and the human IL-1 receptor 1 arranged inline and fused to the Fc portion of human IgG1. Groups of isolated rat pancreatic islets were maintained in medium culture with or without IL-1beta (150 pmol/l) for 48 hours in the absence or presence of the IL-1 trap at 1-, 10-, or 100-fold excess the molar concentration of the cytokine. IL-1beta alone induced a strong inhibition of insulin secretion and glucose oxidation rate and a marked increase in medium nitrite accumulation as an indicator of nitric oxide generation. When the IL-1 trap was used at a ratio 10:1 or 100:1, a complete protection against these effects were observed. Moreover, the IL-1 trap (100:1) blocked the increased islet cell death seen in islets treated with a combination of IL-1beta + tumor necrosis factor-alpha + interferon-gamma as well as functional suppression induced by the cytoki...Continue Reading

References

Apr 1, 1983·Cryobiology·A Andersson, S Sandler
May 1, 1994·The Journal of Clinical Investigation·D L EizirikC Hellerström
Sep 1, 1994·Diabetologia·J NerupT Lorenzen
Jul 15, 1994·Biochemical and Biophysical Research Communications·J O SandbergS Sandler
Apr 19, 1996·Molecular and Cellular Endocrinology·D L EizirikI C Green
Sep 1, 1996·Diabetologia·T Mandrup-Poulsen
Jan 1, 1997·Advances in Experimental Medicine and Biology·C A DelaneyI C Green
Feb 4, 1999·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·H Rothe, H Kolb
Feb 22, 2001·Biochemical and Biophysical Research Communications·A K AnderssonS Sandler
Mar 29, 2001·Diabetes·D L Eizirik, M I Darville
Jan 17, 2002·Diabetologia·D L Eizirik, T Mandrup-Poulsen
Dec 17, 2002·Nature Medicine·Aris N EconomidesNeil Stahl
Jul 5, 2003·Clinical Pharmacology and Therapeutics·Bing-Bing YangJohn T Sullivan
Sep 23, 2003·Reviews in Endocrine & Metabolic Disorders·Alex Rabinovitch, Wilma L Suarez-Pinzon
Oct 28, 2003·Diabetes·Malin Flodström-TullbergNora Sarvetnick
Jul 15, 2004·Current Opinion in Pharmacology·Charles A Dinarello
Mar 26, 2005·Immunological Reviews·Roberto Gianani, George S Eisenbarth
Apr 12, 2005·Drugs of Today·Jean M Jasinski, George S Eisenbarth
May 4, 2005·The Journal of Experimental Medicine·Charles A Dinarello
Jun 30, 2005·Arthritis and Rheumatism·Charles A Dinarello

❮ Previous
Next ❯

Citations

Nov 17, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yalin EmreDaniel Ricquier
Apr 1, 2009·Journal of Cellular Physiology·Alice SchwarznauLuis A Fernandez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.